Economic Burden of Sickle Cell Disease in Nigeria: When Treatment Costs More Than Survival
By Precious Nwonu In Nigeria, sickle cell disease (SCD) affects an estimated 2–3% of the population, with roughly 150,000 babies born with the condition each year. Beyond the medical challenges, the financial toll on families is staggering, deeply entwined with the country’s harsh economic realities. Routine management including regular consultations, blood tests, hydroxyurea, and folic acid medications can cost tens …
Read More »
National Wire About Nigerians, Nigerian Business and Other Stories